ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

ClinicalTrials.gov ID: NCT06914908

Public ClinicalTrials.gov record NCT06914908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study

Study identification

NCT ID
NCT06914908
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
64 participants

Conditions and interventions

Interventions

  • Mometasone furoate nasal spray (MFNS) Drug
  • lunsekimig Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 11, 2025
Primary completion
Jan 28, 2031
Completion
Jan 28, 2031
Last update posted
Apr 27, 2026

2025 – 2031

United States locations

U.S. sites
9
U.S. states
5
U.S. cities
9
Facility City State ZIP Site status
Modena Allergy + Asthma- Site Number : 8400005 La Jolla California 92037 Recruiting
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400003 Roseville California 95661 Recruiting
Treasure Valley Medical Research- Site Number : 8400002 Boise Idaho 83706 Active, not recruiting
Essential Medical Research- Site Number : 8400020 Tulsa Oklahoma 74137 Recruiting
McGovern Medical School - UT Physicians Dermatology - Bellaire Station- Site Number : 8400017 Bellaire Texas 77401 Recruiting
Pharmaceutical Research & Consulting- Site Number : 8400004 Dallas Texas 75231 Recruiting
ENT Associates of Texas - McKinne- Site Number : 8400014 McKinney Texas 75070 Recruiting
Alamo ENT Associates- Site Number : 8400001 San Antonio Texas 78258 Recruiting
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400008 Norfolk Virginia 23510 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06914908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06914908 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →